Last year, according to the World Economic Forum, 77,000 new ventilators were enough to meet the market demand worldwide. For context, this month …

Little known biotech Aim ImmunoTech (AIM) has soared by a massive 382% year-to-date. Yet, Maxim’s analyst Jason McCarthy argues the $75 million market …

Is anything going to stop Amazon’s (AMZN) march towards world domination? It certainly won’t be COVID-19.

Beyond Meat (BYND) worn a few hats since becoming publicly traded in May last year. From May to July BYND stock wore the …

Zoom’s (ZM) penetration of the mainstream came seemingly out of nowhere. It is hard to remember that outside of business circles, not many …

Tesla (TSLA) and its mercurial CEO Elon Musk are never far from the headlines and not always for the right reasons, but last …

Until flaws regarding Zoom’s (ZM) security started botching its mercurial ascent, you could argue the videoconferencing platform was the out and out tech …

With a market cap of a miniscule $10.16 million, you can firmly place biotech Capricor Therapeutics (CAPR) in the nano cap section.

Gilead Sciences (GILD) has positioned itself at the front line in the global war against COVID-19. The biotech’s experimental drug remdesivir is currently …

Every time a door shuts, another window of opportunity opens, the old saying sort of goes. At least that is how one analyst …